Literature DB >> 1911215

Phorbol ester and bryostatin effects on growth and the expression of oestrogen responsive and TGF-beta 1 genes in breast tumour cells.

J E Nutt1, A L Harris, J Lunec.   

Abstract

The phorbol ester, 12-O-tetradecanoylphorbol-13-acetate (TPA) (10 nM) produce a marked reduction in the growth, measured by thymidine uptake, of MCF-7 cells in full growth medium, but had only a small effect on MDA-MB-231 and T47D cells. Bryostatin alone also inhibited growth but to a lesser extent than seen with TPA. The effect of TPA on MCF-7 cells was partially reversed by bryostatin, added simultaneously or after TPA, suggesting bryostatin does not simply mimic TPA in this system. Even though both are believed to act via effects on protein kinase C, bryostatin appears to act as antagonist to the effect of TPA as well as a partial agonist on its own. When the oestrogen receptor positive MCF-7 and T47D cells were maintained in charcoal stripped serum, the increase in DNA synthesis on stimulation with oestradiol was inhibited with 50 nM TPA in MCF-7 cells but not in T47D cells. The effects of these treatments on the expression of two well characterised oestrogen responsive genes pNR2(pS2) and pNR100 (Cathepsin-D) were examined. Rather than preventing transcription of these oestrogen responsive genes, TPA alone increased pNR2 and pNR100 levels in MCF-7 cells and the combined effect of oestradiol and TPA had a marked synergistic effect in increasing the transcript levels of these genes. In T47D cells pNR2 transcripts were not detected and the increase in pNR100 mRNA levels were not affected by TPA. We conclude that the inhibitory effects of TPA on the growth stimulation of MCF-7 cells by oestradiol was not due to a general inhibition of the expression of oestrogen responsive genes. An alternative possibility examined was that the growth inhibitory effect of TPA on MCF-7 cells might be due to stimulation of TGF-beta 1, acting as an autocrine inhibitory growth factor. Oestradiol treatment of MCF-7 cells reduced the levels of TGF-beta 1 mRNA whereas TPA produced a marked increase. The combined effect of TPA and oestradiol further increased TGF-beta 1 mRNA above the levels seen with TPA alone. Bryostatin had little effect on TGF-beta 1 expression either alone or in combination with oestradiol. These observations are consistent with the hypothesis that the inhibitory effect of TPA on MCF-7 cells may be partly due to autocrine inhibition by TGF-beta 1.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1911215      PMCID: PMC1977682          DOI: 10.1038/bjc.1991.379

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  39 in total

1.  Varied differentiation responses of human leukemias to bryostatin 1.

Authors:  A S Kraft; F William; G R Pettit; M B Lilly
Journal:  Cancer Res       Date:  1989-03-01       Impact factor: 12.701

2.  Effects of activators of protein kinase C, including bryostatins 1 and 2, on the growth of A549 human lung carcinoma cells.

Authors:  I L Dale; A Gescher
Journal:  Int J Cancer       Date:  1989-01-15       Impact factor: 7.396

3.  Bryostatin 1 antagonizes the terminal differentiating action of 12-O-tetradecanoylphorbol-13-acetate in a human colon cancer cell.

Authors:  J A McBain; G R Pettit; G C Mueller
Journal:  Carcinogenesis       Date:  1988-01       Impact factor: 4.944

4.  Protein kinase C desensitization by phorbol esters and its impact on growth of human breast cancer cells.

Authors:  D Fabbro; R Regazzi; S D Costa; C Borner; U Eppenberger
Journal:  Biochem Biophys Res Commun       Date:  1986-02-26       Impact factor: 3.575

5.  Continuous synthesis of two protein-kinase-C-related proteins after down-regulation by phorbol esters.

Authors:  C Borner; U Eppenberger; R Wyss; D Fabbro
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

6.  Transforming growth factors type beta 1 and beta 2 are equipotent growth inhibitors of human breast cancer cell lines.

Authors:  G Zugmaier; B W Ennis; B Deschauer; D Katz; C Knabbe; G Wilding; P Daly; M E Lippman; R B Dickson
Journal:  J Cell Physiol       Date:  1989-11       Impact factor: 6.384

7.  Effects of bryostatins and retinoic acid on phorbol ester- and diacylglycerol-induced squamous differentiation in human tracheobronchial epithelial cells.

Authors:  A M Jetten; M A George; G R Pettit; J I Rearick
Journal:  Cancer Res       Date:  1989-07-15       Impact factor: 12.701

8.  TPA induces subcellular translocation and subsequent down-regulation of both phorbol ester binding and protein kinase C activities in MCF-7 cells.

Authors:  J M Darbon; F Oury; S Clamens; F Bayard
Journal:  Biochem Biophys Res Commun       Date:  1987-07-31       Impact factor: 3.575

9.  Inhibition of MCF-7 cell growth by 12-O-tetradecanoylphorbol-13-acetate and 1,2-dioctanoyl-sn-glycerol: distinct effects on protein kinase C activity.

Authors:  M Issandou; F Bayard; J M Darbon
Journal:  Cancer Res       Date:  1988-12-01       Impact factor: 12.701

10.  Three activators of protein kinase C, bryostatins, dioleins, and phorbol esters, show differing specificities of action on GH4 pituitary cells.

Authors:  J S Ramsdell; G R Pettit; A H Tashjian
Journal:  J Biol Chem       Date:  1986-12-25       Impact factor: 5.157

View more
  6 in total

1.  Effect of TPA and HTLV-1 Tax on BRCA1 and ERE controlled genes expression.

Authors:  Azhar Jabareen; Aya Abu-Jaafar; Ammar Abou-Kandil; Mahmoud Huleihel
Journal:  Cell Cycle       Date:  2017-06-08       Impact factor: 4.534

Review 2.  Review of survival analyses published in cancer journals.

Authors:  D G Altman; B L De Stavola; S B Love; K A Stepniewska
Journal:  Br J Cancer       Date:  1995-08       Impact factor: 7.640

3.  hEGR1 is induced by EGF, inhibited by gefitinib in bladder cell lines and related to EGF receptor levels in bladder tumours.

Authors:  J E Nutt; P A Foster; J K Mellon; J Lunec
Journal:  Br J Cancer       Date:  2007-02-20       Impact factor: 7.640

4.  Matrix metalloproteinase-1 is induced by epidermal growth factor in human bladder tumour cell lines and is detectable in urine of patients with bladder tumours.

Authors:  J E Nutt; J K Mellon; K Qureshi; J Lunec
Journal:  Br J Cancer       Date:  1998-07       Impact factor: 7.640

5.  A phase I trial of bryostatin 1 in patients with advanced malignancy using a 24 hour intravenous infusion.

Authors:  G C Jayson; D Crowther; J Prendiville; A T McGown; C Scheid; P Stern; R Young; P Brenchley; J Chang; S Owens
Journal:  Br J Cancer       Date:  1995-08       Impact factor: 7.640

6.  Relationship between tamoxifen-induced transforming growth factor beta 1 expression, cytostasis and apoptosis in human breast cancer cells.

Authors:  R R Perry; Y Kang; B R Greaves
Journal:  Br J Cancer       Date:  1995-12       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.